Monster Beverage Corp vs Oscar Health Inc — how do they compare? Monster Beverage Corp trades at $43.64 (market cap $85.51B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Monster Beverage Corp is far larger — about 8.4× Oscar Health Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, Monster Beverage Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Monster Beverage Corp for 72 Days and Oscar Health Inc for 15 Days on average.
| MNST | OSCR | |
|---|---|---|
Market Cap | $85.51B | $10.22B |
Volume | 8,569,709 | 4,123,394 |
Sector | Consumer Staples | Health |
52-Week High | $49.97 | $33.81 |
52-Week Low | $33.16 | $10.85 |
Typical Hold Time | 72 Days | 15 Days |
Enterprise Value | $83.81B | $6.57B |
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.65, up 1.8% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $0.30 exceeding expectations. Revenue growth accelerated to $8.29B in 2025 with impressive 23.08% net margins. Analyst consensus is bullish with 52% buy ratings and $98.22 price target, representing 125% upside potential. Recent 1:2 stock split on August 11, 2026, enhances accessibility while maintaining zero long-term debt.
MNST presents compelling growth prospects with international expansion driving 35% sales surge and clean balance sheet. However, elevated valuation multiples (P/E 40.42) and regulatory challenges in key markets like India pose risks. The stock's technical strength and fundamental momentum support continued upside, though investors should monitor margin pressures from inflation and competitive dynamics in the energy drink sector.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →